These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 17109465

  • 21. JNK2 negatively regulates CD8+ T cell effector function and anti-tumor immune response.
    Tao J, Gao Y, Li MO, He W, Chen L, Harvev B, Davis RJ, Flavell RA, Yin Z.
    Eur J Immunol; 2007 Mar; 37(3):818-29. PubMed ID: 17301952
    [Abstract] [Full Text] [Related]

  • 22. Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity.
    Hamdy S, Molavi O, Ma Z, Haddadi A, Alshamsan A, Gobti Z, Elhasi S, Samuel J, Lavasanifar A.
    Vaccine; 2008 Sep 15; 26(39):5046-57. PubMed ID: 18680779
    [Abstract] [Full Text] [Related]

  • 23. Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways.
    Miyake T, Kumagai Y, Kato H, Guo Z, Matsushita K, Satoh T, Kawagoe T, Kumar H, Jang MH, Kawai T, Tani T, Takeuchi O, Akira S.
    J Immunol; 2009 Aug 15; 183(4):2522-8. PubMed ID: 19635904
    [Abstract] [Full Text] [Related]

  • 24. CpG-ODN-based immunotherapy is effective in controlling the growth of metastasized tumor cells.
    Kim HA, Ko HM, Ju HW, Kim KJ, Roh SG, Lee HK, Im SY.
    Cancer Lett; 2009 Feb 08; 274(1):160-4. PubMed ID: 18952369
    [Abstract] [Full Text] [Related]

  • 25. Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.
    Sundstedt A, Celander M, Hedlund G.
    Int Immunopharmacol; 2008 Mar 08; 8(3):442-52. PubMed ID: 18279798
    [Abstract] [Full Text] [Related]

  • 26. Intra-tumoral Salmonella typhimurium induces a systemic anti-tumor immune response that is directed by low-dose radiation to treat distal disease.
    Avogadri F, Mittal D, Saccheri F, Sarrafiore M, Ciocca M, Larghi P, Orecchia R, Rescigno M.
    Eur J Immunol; 2008 Jul 08; 38(7):1937-47. PubMed ID: 18581324
    [Abstract] [Full Text] [Related]

  • 27. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.
    Jiang Q, Wei H, Tian Z.
    BMC Cancer; 2008 Jan 17; 8():12. PubMed ID: 18199340
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunity.
    Kosaka A, Wakita D, Matsubara N, Togashi Y, Nishimura S, Kitamura H, Nishimura T.
    Int Immunol; 2007 Mar 17; 19(3):249-56. PubMed ID: 17229818
    [Abstract] [Full Text] [Related]

  • 30. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines.
    Yamaguchi S, Tatsumi T, Takehara T, Sakamori R, Uemura A, Mizushima T, Ohkawa K, Storkus WJ, Hayashi N.
    Cancer; 2007 Oct 01; 110(7):1469-77. PubMed ID: 17685394
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Polyinosinic-polycytidylic acid liposome induces human hepatoma cells apoptosis which correlates to the up-regulation of RIG-I like receptors.
    Peng S, Geng J, Sun R, Tian Z, Wei H.
    Cancer Sci; 2009 Mar 01; 100(3):529-36. PubMed ID: 19154402
    [Abstract] [Full Text] [Related]

  • 36. Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3-IRF3 signaling and type I interferons in dendritic cells.
    Wang C, Zhuang Y, Zhang Y, Luo Z, Gao N, Li P, Pan H, Cai L, Ma Y.
    Vaccine; 2012 Jul 06; 30(32):4790-9. PubMed ID: 22634298
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.